cardiovascular

photo of the wind blowing a tree into a 90-degree angle toward the left
Biotech

Windtree's shock med raises blood pressure in latest phase 2 win

While Windtree has struggled to grow the financial roots to thrive, a win for its lead asset should give the company encouragement to persevere.
James Waldron Sep 25, 2024 9:59am
SPAC special purpose acquisition company

Medera plans SPAC merger to advance cardiac gene therapies

Sep 5, 2024 10:50am
math concepts

Pfizer and Flagship add Quotient to multibillion-dollar equation

Aug 28, 2024 6:30am
photo of the wind blowing a tree into a 90-degree angle toward the left

Despite cash infusion, Windtree still needs rescue within a year

Aug 21, 2024 5:45am
pond lilly pads

Arrowhead dips toes into obesity pond with 2 preclinical assets

Aug 14, 2024 3:50pm
heart money

Cardio-focused Cardurion raises hearty $260M series B

Jul 16, 2024 3:47pm